Familiar Therapeutics is a Redwood City, California-based biotechnology company that adapts medicines first developed for humans into new therapeutics for dogs and cats. It licenses veterinary rights to drug candidates with years of human research behind them and leads the animal-specific clinical development, manufacturing and FDA regulatory work needed for approval, aiming to cut years off typical animal-drug development timelines. Founded in May 2026 by Science Exchange co-founders Elizabeth Iorns and Dan Knox, the company runs a 13-program pipeline spanning oncology, neurology, cardiology, respiratory disease and immunology and partners with biopharma companies that keep human rights and share in veterinary sales.
1
Round
1
Industry
4
Tags
Oct 22, 2026
Latest raise
Funding activity · 1 round
Oct 22, 2026
$5M
Seed
Led by Icehouse Ventures
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
